🏗️Profile under construction 🚧
www.stiftung-charite.de. This support enables us to build a patient-derived neuroblastoma tumoroid platform at Charité – Universitätsmedizin Berlin.
www.stiftung-charite.de. This support enables us to build a patient-derived neuroblastoma tumoroid platform at Charité – Universitätsmedizin Berlin.
Visit us at 👉 clinicalcanevo.com
Learn more about our research, people, and vision — and stay tuned for updates! #CanEvo #CancerResearch #PediatricOncology #TeamScience #TranslationalResearch
Visit us at 👉 clinicalcanevo.com
Learn more about our research, people, and vision — and stay tuned for updates! #CanEvo #CancerResearch #PediatricOncology #TeamScience #TranslationalResearch
Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April.
2026.eacr.org
Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April.
2026.eacr.org
Looking forward to great science and discussions on translating research into better outcomes for children with #Neuroblastoma.
Looking forward to great science and discussions on translating research into better outcomes for children with #Neuroblastoma.
Very grateful to the „Verein der Freunde und Förderer der Charité e.V.“ for supporting me with a travel grant.
It’s been truly inspiring – looking forward to the next one!
Reporting from the MSCC in Bonn, Klara from the CanEvo lab.
Very grateful to the „Verein der Freunde und Förderer der Charité e.V.“ for supporting me with a travel grant.
It’s been truly inspiring – looking forward to the next one!
Reporting from the MSCC in Bonn, Klara from the CanEvo lab.
Exciting conversations and valuable insides! #GermanCancerAid #MSCC
Exciting conversations and valuable insides! #GermanCancerAid #MSCC
He delivered a deep dive into the KRAS-ERK-MYC signalling network and how to target it for therapy. #GermanCancerAid #MSCC
He delivered a deep dive into the KRAS-ERK-MYC signalling network and how to target it for therapy. #GermanCancerAid #MSCC
#DeutscheKrebshilfe #MSCC #Charité
#DeutscheKrebshilfe #MSCC #Charité
New study by @al2na.bsky.social from #mdcBerlin:
✔️ 97% accuracy in specialist referrals
✔️ 82% in diagnosis
⚠️ Triage still needs work
👉 Interview: www.helmholtz.de/en/newsroom/...
👉 Study: www.mdc-berlin.de/news/news/ai...
New study by @al2na.bsky.social from #mdcBerlin:
✔️ 97% accuracy in specialist referrals
✔️ 82% in diagnosis
⚠️ Triage still needs work
👉 Interview: www.helmholtz.de/en/newsroom/...
👉 Study: www.mdc-berlin.de/news/news/ai...